568 related articles for article (PubMed ID: 9734360)
1. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.
Desterro JM; Rodriguez MS; Hay RT
Mol Cell; 1998 Aug; 2(2):233-9. PubMed ID: 9734360
[TBL] [Abstract][Full Text] [Related]
2. Control of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alpha.
Hay RT; Vuillard L; Desterro JM; Rodriguez MS
Philos Trans R Soc Lond B Biol Sci; 1999 Sep; 354(1389):1601-9. PubMed ID: 10582246
[TBL] [Abstract][Full Text] [Related]
3. Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo.
Roff M; Thompson J; Rodriguez MS; Jacque JM; Baleux F; Arenzana-Seisdedos F; Hay RT
J Biol Chem; 1996 Mar; 271(13):7844-50. PubMed ID: 8631829
[TBL] [Abstract][Full Text] [Related]
4. Transient nuclear factor kappaB (NF-kappaB) activation stimulated by interleukin-1beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IkappaBalpha molecule, in C6 glioma cells. Regulation of NF-kappaB linked to chemokine production.
Uehara T; Matsuno J; Kaneko M; Nishiya T; Fujimuro M; Yokosawa H; Nomura Y
J Biol Chem; 1999 May; 274(22):15875-82. PubMed ID: 10336492
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation.
Han Y; Weinman S; Boldogh I; Walker RK; Brasier AR
J Biol Chem; 1999 Jan; 274(2):787-94. PubMed ID: 9873017
[TBL] [Abstract][Full Text] [Related]
6. Heterologous SUMO-2/3-ubiquitin chains optimize IκBα degradation and NF-κB activity.
Aillet F; Lopitz-Otsoa F; Egaña I; Hjerpe R; Fraser P; Hay RT; Rodriguez MS; Lang V
PLoS One; 2012; 7(12):e51672. PubMed ID: 23284737
[TBL] [Abstract][Full Text] [Related]
7. Inducible NF-kappaB activation is permitted by simultaneous degradation of nuclear IkappaBalpha.
Renard P; Percherancier Y; Kroll M; Thomas D; Virelizier JL; Arenzana-Seisdedos F; Bachelerie F
J Biol Chem; 2000 May; 275(20):15193-9. PubMed ID: 10809754
[TBL] [Abstract][Full Text] [Related]
8. Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha.
Mukhopadhyay A; Manna SK; Aggarwal BB
J Biol Chem; 2000 Mar; 275(12):8549-55. PubMed ID: 10722693
[TBL] [Abstract][Full Text] [Related]
9. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848
[TBL] [Abstract][Full Text] [Related]
10. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo.
Rodriguez MS; Wright J; Thompson J; Thomas D; Baleux F; Virelizier JL; Hay RT; Arenzana-Seisdedos F
Oncogene; 1996 Jun; 12(11):2425-35. PubMed ID: 8649784
[TBL] [Abstract][Full Text] [Related]
11. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.
Chen Z; Hagler J; Palombella VJ; Melandri F; Scherer D; Ballard D; Maniatis T
Genes Dev; 1995 Jul; 9(13):1586-97. PubMed ID: 7628694
[TBL] [Abstract][Full Text] [Related]
12. Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required.
Van Antwerp DJ; Verma IM
Mol Cell Biol; 1996 Nov; 16(11):6037-45. PubMed ID: 8887633
[TBL] [Abstract][Full Text] [Related]
13. A MEK inhibitor, PD98059 enhances IL-1-induced NF-kappaB activation by the enhanced and sustained degradation of IkappaBalpha.
Funakoshi M; Tago K; Sonoda Y; Tominaga S; Kasahara T
Biochem Biophys Res Commun; 2001 Apr; 283(1):248-54. PubMed ID: 11322796
[TBL] [Abstract][Full Text] [Related]
14. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
Roussel RR; Barchowsky A
Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
[TBL] [Abstract][Full Text] [Related]
15. Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms.
Li N; Karin M
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13012-7. PubMed ID: 9789032
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro recruitment of an IkappaBalpha-ubiquitin ligase to IkappaBalpha phosphorylated by IKK, leading to ubiquitination.
Suzuki H; Chiba T; Kobayashi M; Takeuchi M; Furuichi K; Tanaka K
Biochem Biophys Res Commun; 1999 Mar; 256(1):121-6. PubMed ID: 10066434
[TBL] [Abstract][Full Text] [Related]
17. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1.
Desterro JM; Rodriguez MS; Kemp GD; Hay RT
J Biol Chem; 1999 Apr; 274(15):10618-24. PubMed ID: 10187858
[TBL] [Abstract][Full Text] [Related]
18. Activation of the ubiquitin proteolytic system in murine acquired immunodeficiency syndrome affects IkappaBalpha turnover.
Crinelli R; Bianchi M; Gentilini L; Magnani M; Hiscott J
Eur J Biochem; 1999 Jul; 263(1):202-11. PubMed ID: 10429205
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressant FK506 activates NF-kappaB through the proteasome-mediated degradation of IkappaBalpha. Requirement for Ikappabalpha n-terminal phosphorylation but not ubiquitination sites.
Zhang Y; Sun X; Muraoka K; Ikeda A; Miyamoto S; Shimizu H; Yoshioka K; Yamamoto K
J Biol Chem; 1999 Dec; 274(49):34657-62. PubMed ID: 10574930
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 activates the transcription factor NFkappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha.
de Moissac D; Mustapha S; Greenberg AH; Kirshenbaum LA
J Biol Chem; 1998 Sep; 273(37):23946-51. PubMed ID: 9727009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
